NHI reimbursement to grant for 103 new products.

The MOHW announced on Oct. 17 that the NHI reimbursement coverage would be extended to 103 new products including 12 orphan drugs for the treatment of multisclerosis and other incurable diseases, for which about 16 billion won of budget be allocated.

So far the NHI reimbursement for injectable Interferon limited to an authorized scope of its indications, but the new provision granted to an u...